Literature DB >> 6386609

Bacterial pneumonia in the elderly: clinical features, diagnosis, etiology, and treatment.

D W Bentley.   

Abstract

Diagnosis of bacterial pneumonia in the elderly depends on an awareness of the various forms of presentation and identification of the etiologic agent(s). The reliability of sputum or nasopharyngeal aspirates can be assessed by the number of squamous epithelial cells and white blood cells per 100 X field (low-power). Transtracheal aspiration should be considered in select patients with life-threatening pneumonias. Community-acquired pneumonias are caused primarily by S. pneumoniae (40-60%), hospital-acquired pneumonias by gram-negative bacilli (45%) and institution-acquired pneumonias by mixed flora (35%) and S. pneumoniae (30%). Initial choice of antimicrobial agents is based on an interpretation of the Gram stain. Choice of empiric antimicrobial treatment depends on host characteristics and the setting in which the pneumonia occurs.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6386609     DOI: 10.1159/000212649

Source DB:  PubMed          Journal:  Gerontology        ISSN: 0304-324X            Impact factor:   5.140


  9 in total

1.  Infections in the older population: what do we know?

Authors:  Didier Schoevaerdts; François-Xavier Sibille; Gaetan Gavazzi
Journal:  Aging Clin Exp Res       Date:  2019-10-26       Impact factor: 3.636

2.  The significance of pneumonia in the elderly.

Authors:  G Rosenberg
Journal:  Can Fam Physician       Date:  1987-05       Impact factor: 3.275

Review 3.  Infections and antibiotic resistance in nursing homes.

Authors:  L E Nicolle; L J Strausbaugh; R A Garibaldi
Journal:  Clin Microbiol Rev       Date:  1996-01       Impact factor: 26.132

4.  Assessment of pneumonia in older adults: effect of functional status.

Authors:  Lona Mody; Rongjun Sun; Suzanne F Bradley
Journal:  J Am Geriatr Soc       Date:  2006-07       Impact factor: 5.562

5.  Role of pathogenic oral flora in postoperative pneumonia following brain surgery.

Authors:  Kinga Bágyi; Angela Haczku; Ildikó Márton; Judit Szabó; Attila Gáspár; Melinda Andrási; Imre Varga; Judit Tóth; Almos Klekner
Journal:  BMC Infect Dis       Date:  2009-06-29       Impact factor: 3.090

6.  Ampicillin versus cefamandole as initial therapy for community-acquired pneumonia.

Authors:  D J Weber; S B Calderwood; A W Karchmer; J E Pennington
Journal:  Antimicrob Agents Chemother       Date:  1987-06       Impact factor: 5.191

7.  Chronic Morganella morganii arthritis in an elderly patient.

Authors:  R S Schonwetter; F M Orson
Journal:  J Clin Microbiol       Date:  1988-07       Impact factor: 5.948

8.  Randomized comparative trial with ampicillin/sulbactam versus cefamandole in the therapy of community acquired pneumonia.

Authors:  D Williams; M Perri; M J Zervos
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-04       Impact factor: 3.267

9.  Estimate of CRP and TNF-alpha level before and after periodontal therapy in cardiovascular disease patients.

Authors:  Pradeep Koppolu; Satyanarayana Durvasula; Rajababu Palaparthy; Mukhesh Rao; Vidya Sagar; Sunil Kumar Reddy; Swapna Lingam
Journal:  Pan Afr Med J       Date:  2013-07-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.